secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001140361-24-039592
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics CFO Brian Piekos resigns effective September 6, 2024
------------------------------------------------------------------------

- CFO Brian Piekos notified Company of resignation on Aug 27, 2024, to pursue other opportunity.
- Resignation effective September 6, 2024; no disagreement on financial reporting or accounting matters.
- Company has initiated search for a new Chief Financial Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000114036124039592/0001140361-24-039592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000114036124039592/ef20035237_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-039592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer